182 related articles for article (PubMed ID: 28743061)
1. Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance.
Jia Y; Luo X; Ji Y; Xie J; Jiang H; Fu M; Li X
Diabetes Res Clin Pract; 2017 Sep; 131():116-123. PubMed ID: 28743061
[TBL] [Abstract][Full Text] [Related]
2. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans.
Hwang YC; Woo Oh S; Park SW; Park CY
Int J Obes (Lond); 2014 Sep; 38(9):1207-12. PubMed ID: 24357853
[TBL] [Abstract][Full Text] [Related]
3. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose.
Bai B; Ban B; Liu Z; Zhang MM; Tan BK; Chen J
PLoS One; 2017; 12(2):e0172271. PubMed ID: 28207876
[TBL] [Abstract][Full Text] [Related]
4. Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes.
Jung CH; Lee MJ; Kang YM; Jang JE; Leem J; Lee YL; Seol SM; Yoon HK; Lee WJ; Park JY
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2477-84. PubMed ID: 25105737
[TBL] [Abstract][Full Text] [Related]
5. C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery.
Wolf RM; Steele KE; Peterson LA; Zeng X; Jaffe AE; Schweitzer MA; Magnuson TH; Wong GW
J Clin Endocrinol Metab; 2016 May; 101(5):2211-7. PubMed ID: 26982010
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of C1q/TNF-Related Protein 3 (CTRP3) and CTRP9 in Gestational Diabetes and Their Association with Insulin Resistance and Inflammatory Cytokines.
Fadaei R; Goodarzi G; Yarahmadi S; Allahyari P; Fallah S; Moradi N
Lab Med; 2023 May; 54(3):262-269. PubMed ID: 36219707
[TBL] [Abstract][Full Text] [Related]
7. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.
Moradi N; Fadaei R; Emamgholipour S; Kazemian E; Panahi G; Vahedi S; Saed L; Fallah S
PLoS One; 2018; 13(1):e0192159. PubMed ID: 29381773
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice.
Wei Z; Lei X; Petersen PS; Aja S; Wong GW
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E779-90. PubMed ID: 24473438
[TBL] [Abstract][Full Text] [Related]
9. Serum C1q and tumor necrosis factor (TNF)-related protein 9 in women with Polycystic Ovary Syndrome.
Forouhi N; Saedisomeolia A; Djalali M; Eshraghian MR; Morshedzadeh N; Zabetian-Targhi F; Mahmoudi M
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S131-4. PubMed ID: 27025792
[TBL] [Abstract][Full Text] [Related]
10. Myonectin Predicts the Development of Type 2 Diabetes.
Li K; Liao X; Wang K; Mi Q; Zhang T; Jia Y; Xu X; Luo X; Zhang C; Liu H; Zhen H; Li L; Yang G
J Clin Endocrinol Metab; 2018 Jan; 103(1):139-147. PubMed ID: 29161407
[TBL] [Abstract][Full Text] [Related]
11. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
12. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
[TBL] [Abstract][Full Text] [Related]
13. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
[TBL] [Abstract][Full Text] [Related]
14. Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction.
Asada M; Morioka T; Yamazaki Y; Kakutani Y; Kawarabayashi R; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
J Diabetes Res; 2016; 2016():8624313. PubMed ID: 28070523
[No Abstract] [Full Text] [Related]
15. Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus.
Yang J; Zhao D; Chen Y; Ma Y; Shi X; Wang X; Lv Y; Yuan H
J Diabetes Investig; 2021 Aug; 12(8):1442-1451. PubMed ID: 33417302
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance.
Luo R; Li X; Jiang R; Gao X; Lü Z; Hua W
J Int Med Res; 2012; 40(2):621-30. PubMed ID: 22613423
[TBL] [Abstract][Full Text] [Related]
17. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
18. Plasma fetuin-B concentrations are associated with insulin resistance and first-phase glucose-stimulated insulin secretion in individuals with different degrees of glucose tolerance.
Qu H; Qiu Y; Wang Y; Liao Y; Zheng Y; Zheng H
Diabetes Metab; 2018 Dec; 44(6):488-492. PubMed ID: 29514765
[TBL] [Abstract][Full Text] [Related]
19. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
20. Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
Yang M; Liu R; Li S; Luo Y; Zhang Y; Zhang L; Liu D; Wang Y; Xiong Z; Boden G; Chen S; Li L; Yang G
Diabetes Care; 2013 May; 36(5):1074-82. PubMed ID: 23275352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
